Navigate to
← Back to Overview
Pharmaceutical Manufacturing & Healthcare

Pharmaceuticals.

A $4 billion market growing at 12% annually, with 800+ licensed manufacturers and rising export demand. CZAAH facilitates market entry, manufacturing partnerships, and regulatory navigation for international pharmaceutical investors.

Explore Partnerships →

Product catalog.

Pakistan's pharmaceutical manufacturing covers a comprehensive range of products — from high-volume generics to precision surgical instruments.

Generic Medicines

Pakistan supplies affordable, WHO GMP-certified generic medicines to over 80 countries, offering up to 70% cost savings versus branded equivalents.

800+
Manufacturers
$500M+
Annual Exports
70%
Cost Saving vs Branded
Key Products
  • Cardiovascular
  • Anti-infectives
  • CNS
  • Gastrointestinal
  • Respiratory
Certifications
  • WHO GMP
  • ISO 9001
  • ICH Guidelines
Export Markets
  • Africa
  • Central Asia
  • Gulf
  • Southeast Asia
Enquire →
Active Pharmaceutical Ingredients

Pakistan has a growing API manufacturing base producing over 200 molecules, supporting both domestic formulation and international supply chains.

50+
API Plants
200+
Molecules
$150M+
Annual Exports
Key Products
  • Paracetamol
  • Metformin
  • Amoxicillin
  • Omeprazole
Certifications
  • WHO GMP
  • EU GMP (select)
  • FDA Registered (select)
Export Markets
  • EU
  • USA
  • Gulf
  • Africa
Enquire →
Surgical & Medical Devices

Pakistan is a globally significant exporter of surgical instruments, anchored by the renowned Sialkot manufacturing cluster with over 2,500 manufacturers.

2,500+
Manufacturers
$450M+
Annual Exports
Sialkot
Global Cluster
Key Products
  • Surgical forceps
  • Scissors & retractors
  • Dental instruments
  • Orthopedic implants
Certifications
  • CE Mark
  • FDA 510(k)
  • ISO 13485
Export Markets
  • USA
  • EU
  • Japan
  • Gulf
Enquire →
Nutraceuticals & Supplements

A fast-growing segment fuelled by rising health consciousness, Pakistan's herbal traditions, and strong demand from diaspora communities worldwide.

$200M+
Market Size
25%
Growth YoY
Herbal
Tradition-Based
Key Products
  • Herbal supplements
  • Vitamins
  • Protein powders
  • Dietary supplements
Certifications
  • ISO 22000
  • GMP
  • Halal
Export Markets
  • Gulf
  • UK
  • USA diaspora
Enquire →
Halal Pharmaceuticals

Uniquely positioned to serve the $3 trillion global halal economy and 1.8 billion Muslim consumers with certified halal medicines and formulations.

$3T
Global Halal Economy
1.8B
Muslim Consumers
First
Mover Advantage
Key Products
  • Gelatin-free capsules
  • Halal-certified syrups
  • Plant-based coatings
Certifications
  • Halal (SANHA, JAKIM)
  • WHO GMP
Export Markets
  • Gulf
  • Malaysia
  • Indonesia
  • Turkey
Enquire →
Vaccines & Biologics

An emerging segment backed by government investment, COVID-era capacity expansion, and planned biotech parks positioned for regional supply.

NIH
Islamabad Hub
3
Biotech Parks Planned
COVID
Capacity Built
Key Products
  • Vaccine fill-finish
  • Biosimilars
  • Sera
  • Blood products
Certifications
  • WHO PQ (in progress)
  • GMP
Export Markets
  • Domestic
  • GAVI
  • African Union
Enquire →
Contract Manufacturing

OEM and ODM manufacturing for international pharmaceutical brands, leveraging spare capacity, competitive pricing, and an English-speaking workforce.

30%+
Spare Capacity
Low
Competitive Pricing
English
Speaking Workforce
Key Products
  • Tablets & capsules
  • Syrups
  • Injectables
  • Ointments
Certifications
  • WHO GMP
  • EU GMP (select)
  • ISO 9001
Export Markets
  • Brand-owner directed
Enquire →

Regulatory & compliance.

Pakistan's pharmaceutical regulatory framework aligned with international standards across manufacturing, quality, and product certification.

Certification Governing Body Status Coverage
WHO GMP DRAP Active 400+ certified facilities
ISO 9001:2015 PSQCA Active Standard for all manufacturers
EU GMP EMA via DRAP In Progress 15+ facilities certified
US FDA Registration FDA Active 25+ registered facilities
CE Marking EU Notified Bodies Active Surgical instruments (Sialkot)
ISO 13485 Medical Devices Active 500+ manufacturers
Halal Certification SANHA / JAKIM Active Growing adoption
WHO Prequalification WHO In Progress Vaccines & APIs

Our services.

Pharmaceutical market entry and partnership facilitation across Pakistan's growing healthcare sector.

◆

Market Entry Advisory

Sector analysis, regulatory landscape mapping, and strategic guidance for pharmaceutical companies evaluating Pakistan.

⚙

Manufacturing Partnerships

Connection with licensed Pakistani manufacturers for contract manufacturing, toll manufacturing, and joint venture production facilities.

★

Regulatory Navigation

DRAP (Drug Regulatory Authority of Pakistan) registration, product licensing, GMP compliance, and import/export permits.

⇄

Supply Chain Development

Distribution network access, cold chain logistics, and hospital/pharmacy channel partnerships across Pakistan's 230M+ consumer market.

$

API & Raw Materials

Access to Pakistan's growing Active Pharmaceutical Ingredient production capabilities and raw material sourcing networks.

+

Export Facilitation

International registration support and connection with buyers in Gulf, African, and Central Asian markets through our Dubai trading network.

Pakistan's pharmaceutical sector at a glance.

$4B+
Pharmaceutical market size
800+
Licensed manufacturers
12%
Annual market growth
230M+
Domestic consumer base

Investment opportunities.

High-growth segments within Pakistan's pharmaceutical and healthcare landscape.

◆

Generic Manufacturing

Pakistan's generic drug market is rapidly expanding. Growing domestic demand and export opportunities to underserved markets create strong investment cases.

■

Healthcare Infrastructure

Hospitals, diagnostic centres, and medical supply chains are severely underdeveloped relative to population. Private investment is being actively encouraged.

★

Halal Pharmaceuticals

Growing global demand for halal-certified medicines positions Pakistan as a natural manufacturing hub for Gulf and Southeast Asian markets.

⇄

Biotech & Innovation

Government incentives for biotechnology research and pharmaceutical R&D are creating opportunities for technology-forward investors.

A $4 billion market, growing.

Market entry, manufacturing partnerships, and regulatory navigation for pharmaceutical and healthcare investors.

Discuss Market Entry →